Liver Iron Loading in Alcohol-Associated Liver Disease.


Journal

The American journal of pathology
ISSN: 1525-2191
Titre abrégé: Am J Pathol
Pays: United States
ID NLM: 0370502

Informations de publication

Date de publication:
10 2023
Historique:
received: 29 06 2022
revised: 15 08 2022
accepted: 31 08 2022
medline: 19 9 2023
pubmed: 29 10 2022
entrez: 28 10 2022
Statut: ppublish

Résumé

Alcohol-associated liver disease (ALD) is a common chronic liver disease with increasing incidence worldwide. Alcoholic liver steatosis/steatohepatitis can progress to liver fibrosis/cirrhosis, which can cause predisposition to hepatocellular carcinoma. ALD diagnosis and management are confounded by several challenges. Iron loading is a feature of ALD which can exacerbate alcohol-induced liver injury and promote ALD pathologic progression. Knowledge of the mechanisms that mediate liver iron loading can help identify cellular/molecular targets and thereby aid in designing adjunct diagnostic, prognostic, and therapeutic approaches for ALD. Herein, the cellular mechanisms underlying alcohol-induced liver iron loading are reviewed and how excess iron in patients with ALD can promote liver fibrosis and aggravate disease pathology is discussed. Alcohol-induced increase in hepatic transferrin receptor-1 expression and up-regulation of high iron protein in Kupffer cells (proposed) facilitate iron deposition and retention in the liver. Iron is loaded in both parenchymal and nonparenchymal liver cells. Iron-loaded liver can promote ferroptosis and thereby contribute to ALD pathology. Iron and alcohol can independently elevate oxidative stress. Therefore, a combination of excess iron and alcohol amplifies oxidative stress and accelerates liver injury. Excess iron-stimulated hepatocytes directly or indirectly (through Kupffer cell activation) activate the hepatic stellate cells via secretion of proinflammatory and profibrotic factors. Persistently activated hepatic stellate cells promote liver fibrosis, and thereby facilitate ALD progression.

Identifiants

pubmed: 36306827
pii: S0002-9440(22)00323-6
doi: 10.1016/j.ajpath.2022.08.010
pii:
doi:

Substances chimiques

Iron E1UOL152H7
Ethanol 3K9958V90M

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1427-1439

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2023 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Auteurs

Najma Ali (N)

GKT School of Medical Education, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.

Kevin Ferrao (K)

GKT School of Medical Education, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.

Kosha J Mehta (KJ)

Centre for Education, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom. Electronic address: kosha.mehta@kcl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH